There were 1,794 press releases posted in the last 24 hours and 359,369 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image